Share Price and Basic Stock Data
Last Updated: January 3, 2026, 11:53 am
| PEG Ratio | -1.24 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Meghmani Organics Ltd operates within the agrochemicals and pesticides sector, focusing on producing a range of products that cater to agricultural needs. The company’s revenue trajectory exhibited fluctuations over the past few quarters. Sales reported for March 2023 stood at ₹2,553 Cr, reflecting an increase from ₹2,498 Cr in March 2022. However, the subsequent fiscal year saw a decline, with sales dropping to ₹1,566 Cr in March 2024. A recovery was noted in March 2025, where sales rose to ₹2,080 Cr. In the trailing twelve months, sales reached ₹2,313 Cr, indicating some stabilization. The quarterly sales figures also highlight volatility, with a peak of ₹646 Cr in September 2022, followed by a significant drop to ₹379 Cr in September 2023. This pattern suggests challenges in maintaining consistent demand or production issues, which could be attributed to market dynamics or supply chain disruptions.
Profitability and Efficiency Metrics
Meghmani’s profitability metrics indicate a challenging landscape, particularly regarding operating and net profit margins. The operating profit margin (OPM) for March 2025 recorded at 7%, a notable recovery from a negative margin of -1% in March 2024. However, net profit margins remained under pressure, with a reported net profit of ₹40 Cr for the trailing twelve months, translating to a net profit margin of -0.50%. The company’s return on equity (ROE) stood at 0.80%, which is relatively low compared to industry standards, indicating inefficiencies in generating returns for shareholders. Additionally, the cash conversion cycle averaged 113 days, suggesting potential inefficiencies in working capital management. The interest coverage ratio, however, improved to 2.70x, indicating better capacity to meet interest obligations despite the overall profitability challenges.
Balance Sheet Strength and Financial Ratios
Meghmani’s balance sheet reflects a moderate level of leverage, with total borrowings reported at ₹841 Cr against reserves of ₹1,514 Cr. The debt-to-equity ratio stood at 0.54, indicating a balanced approach to financing, although the interest coverage ratio suggests that the company is managing its debt obligations adequately. The book value per share decreased slightly to ₹59.58 in March 2025 from ₹65.64 in March 2023, indicating a decline in net worth per share. The current ratio of 1.12x suggests that the company is maintaining adequate liquidity to cover short-term liabilities. However, the inventory turnover ratio of 3.73x indicates relatively slow inventory movement, which could be a concern if it reflects overstocking or reduced demand. Overall, while the balance sheet shows some strengths, there are areas requiring improvement, particularly in liquidity management and inventory efficiency.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Meghmani Organics exhibits a significant promoter holding of 48.98%, which can be a positive indicator of management commitment. However, foreign institutional investors (FIIs) only hold 1.48%, reflecting limited confidence from international investors. Domestic institutional investors (DIIs) hold no stake, which could indicate a lack of interest or perceived risk in the stock. The public holding stands at 49.50%, showing a diverse shareholder base with 1,31,853 shareholders as of September 2025. The stability in promoter shareholding over the past year, hovering around 49.32% to 49.50%, suggests confidence from the management in the company’s future prospects. However, the declining trend in institutional participation may raise concerns about broader market confidence in the company’s operational performance and strategic direction.
Outlook, Risks, and Final Insight
The outlook for Meghmani Organics is contingent on its ability to stabilize revenue and improve profitability metrics. Key strengths include its established position in the agrochemical sector and a robust promoter holding, which can foster long-term strategic initiatives. However, risks such as fluctuating sales figures, low net profit margins, and weak institutional interest could undermine investor confidence. The company must address its operational efficiency, particularly in managing working capital and inventory levels, to enhance profitability. A potential scenario for recovery hinges on improved market conditions and operational adjustments that could lead to consistent revenue growth. Conversely, continued volatility in sales and profitability could pose challenges, necessitating strategic pivots to sustain investor interest and market share.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Epigral Ltd | 5,375 Cr. | 1,246 | 2,114/1,213 | 13.4 | 487 | 0.48 % | 24.9 % | 22.3 % | 10.0 |
| Dharmaj Crop Guard Ltd | 829 Cr. | 245 | 391/165 | 17.0 | 131 | 0.00 % | 12.0 % | 9.28 % | 10.0 |
| Bhaskar Agrochemicals Ltd | 63.7 Cr. | 122 | 149/56.6 | 11.4 | 40.0 | 0.00 % | 21.3 % | 24.7 % | 10.0 |
| Bhagiradha Chemicals & Industries Ltd | 2,601 Cr. | 201 | 331/198 | 98.2 | 54.9 | 0.07 % | 7.44 % | 4.91 % | 1.00 |
| Best Agrolife Ltd | 923 Cr. | 390 | 620/244 | 72.1 | 342 | 0.51 % | 12.9 % | 9.95 % | 10.0 |
| Industry Average | 11,195.70 Cr | 1,134.10 | 31.52 | 382.34 | 0.42% | 15.21% | 19.87% | 7.04 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 646 | 549 | 574 | 426 | 379 | 352 | 410 | 414 | 544 | 569 | 553 | 614 | 577 |
| Expenses | 567 | 497 | 496 | 448 | 371 | 360 | 408 | 408 | 513 | 528 | 488 | 547 | 525 |
| Operating Profit | 78 | 53 | 78 | -22 | 8 | -8 | 2 | 6 | 31 | 41 | 65 | 67 | 52 |
| OPM % | 12% | 10% | 14% | -5% | 2% | -2% | 0% | 1% | 6% | 7% | 12% | 11% | 9% |
| Other Income | 26 | 24 | 27 | 7 | 12 | 10 | 9 | 9 | 12 | 9 | 14 | 17 | 28 |
| Interest | -3 | 43 | 16 | 4 | 13 | 27 | 2 | 11 | 26 | 13 | 19 | 29 | 24 |
| Depreciation | 18 | 18 | 23 | 24 | 23 | 23 | 23 | 23 | 25 | 30 | 29 | 30 | 30 |
| Profit before tax | 89 | 15 | 67 | -43 | -16 | -48 | -14 | -19 | -9 | 7 | 31 | 24 | 26 |
| Tax % | 25% | 46% | 19% | -20% | -3% | -20% | 25% | -13% | 1% | 159% | 35% | 48% | 56% |
| Net Profit | 66 | 8 | 54 | -34 | -15 | -38 | -18 | -17 | -9 | -4 | 20 | 13 | 12 |
| EPS in Rs | 2.60 | 0.33 | 2.13 | -1.36 | -0.60 | -1.50 | -0.71 | -0.66 | -0.36 | -0.17 | 0.78 | 0.50 | 0.45 |
Last Updated: December 30, 2025, 12:07 am
Below is a detailed analysis of the quarterly data for Meghmani Organics Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 577.00 Cr.. The value appears to be declining and may need further review. It has decreased from 614.00 Cr. (Jun 2025) to 577.00 Cr., marking a decrease of 37.00 Cr..
- For Expenses, as of Sep 2025, the value is 525.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 547.00 Cr. (Jun 2025) to 525.00 Cr., marking a decrease of 22.00 Cr..
- For Operating Profit, as of Sep 2025, the value is 52.00 Cr.. The value appears to be declining and may need further review. It has decreased from 67.00 Cr. (Jun 2025) to 52.00 Cr., marking a decrease of 15.00 Cr..
- For OPM %, as of Sep 2025, the value is 9.00%. The value appears to be declining and may need further review. It has decreased from 11.00% (Jun 2025) to 9.00%, marking a decrease of 2.00%.
- For Other Income, as of Sep 2025, the value is 28.00 Cr.. The value appears strong and on an upward trend. It has increased from 17.00 Cr. (Jun 2025) to 28.00 Cr., marking an increase of 11.00 Cr..
- For Interest, as of Sep 2025, the value is 24.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 29.00 Cr. (Jun 2025) to 24.00 Cr., marking a decrease of 5.00 Cr..
- For Depreciation, as of Sep 2025, the value is 30.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 30.00 Cr..
- For Profit before tax, as of Sep 2025, the value is 26.00 Cr.. The value appears strong and on an upward trend. It has increased from 24.00 Cr. (Jun 2025) to 26.00 Cr., marking an increase of 2.00 Cr..
- For Tax %, as of Sep 2025, the value is 56.00%. The value appears to be increasing, which may not be favorable. It has increased from 48.00% (Jun 2025) to 56.00%, marking an increase of 8.00%.
- For Net Profit, as of Sep 2025, the value is 12.00 Cr.. The value appears to be declining and may need further review. It has decreased from 13.00 Cr. (Jun 2025) to 12.00 Cr., marking a decrease of 1.00 Cr..
- For EPS in Rs, as of Sep 2025, the value is 0.45. The value appears to be declining and may need further review. It has decreased from 0.50 (Jun 2025) to 0.45, marking a decrease of 0.05.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 4:59 am
| Metric | Mar 2020n n 6m | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|
| Sales | 700 | 1,637 | 2,498 | 2,553 | 1,566 | 2,080 | 2,313 |
| Expenses | 595 | 1,353 | 2,119 | 2,211 | 1,586 | 1,936 | 2,088 |
| Operating Profit | 105 | 283 | 379 | 342 | -19 | 144 | 225 |
| OPM % | 15% | 17% | 15% | 13% | -1% | 7% | 10% |
| Other Income | 130 | 30 | 102 | 114 | 37 | 42 | 67 |
| Interest | 18 | 11 | 9 | 66 | 46 | 69 | 85 |
| Depreciation | 22 | 51 | 63 | 77 | 92 | 108 | 119 |
| Profit before tax | 194 | 252 | 409 | 313 | -121 | 9 | 88 |
| Tax % | 23% | 26% | 26% | 24% | -12% | 212% | |
| Net Profit | 150 | 186 | 304 | 238 | -106 | -11 | 40 |
| EPS in Rs | 29,914.00 | 37,296.00 | 11.97 | 9.35 | -4.17 | -0.42 | 1.56 |
| Dividend Payout % | 17% | 19% | 12% | 15% | -0% | -0% |
YoY Net Profit Growth
| Year | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|
| YoY Net Profit Growth (%) | 63.44% | -21.71% | -144.54% | 89.62% |
| Change in YoY Net Profit Growth (%) | 0.00% | -85.15% | -122.83% | 234.16% |
Meghmani Organics Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 4 years from 2021-2022 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 24% |
| 3 Years: | -6% |
| TTM: | 47% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 121% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | -13% |
| 1 Year: | -25% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 8% |
| 3 Years: | 2% |
| Last Year: | -1% |
Last Updated: Unknown
Balance Sheet
Last Updated: December 4, 2025, 1:38 am
| Month | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|
| Equity Capital | 25 | 25 | 25 | 25 | 25 | 25 | 25 |
| Reserves | 961 | 1,148 | 1,441 | 1,644 | 1,502 | 1,490 | 1,514 |
| Borrowings | 264 | 268 | 499 | 824 | 837 | 829 | 841 |
| Other Liabilities | 407 | 533 | 832 | 705 | 674 | 741 | 905 |
| Total Liabilities | 1,657 | 1,974 | 2,798 | 3,198 | 3,039 | 3,085 | 3,285 |
| Fixed Assets | 481 | 634 | 911 | 1,166 | 1,152 | 1,575 | 1,540 |
| CWIP | 101 | 112 | 188 | 356 | 521 | 83 | 80 |
| Investments | 191 | 304 | 211 | 183 | 114 | 3 | 3 |
| Other Assets | 885 | 924 | 1,487 | 1,494 | 1,251 | 1,425 | 1,662 |
| Total Assets | 1,657 | 1,974 | 2,798 | 3,198 | 3,039 | 3,085 | 3,285 |
Below is a detailed analysis of the balance sheet data for Meghmani Organics Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 25.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 25.00 Cr..
- For Reserves, as of Sep 2025, the value is 1,514.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,490.00 Cr. (Mar 2025) to 1,514.00 Cr., marking an increase of 24.00 Cr..
- For Borrowings, as of Sep 2025, the value is 841.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 829.00 Cr. (Mar 2025) to 841.00 Cr., marking an increase of 12.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 905.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 741.00 Cr. (Mar 2025) to 905.00 Cr., marking an increase of 164.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 3,285.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3,085.00 Cr. (Mar 2025) to 3,285.00 Cr., marking an increase of 200.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 1,540.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,575.00 Cr. (Mar 2025) to 1,540.00 Cr., marking a decrease of 35.00 Cr..
- For CWIP, as of Sep 2025, the value is 80.00 Cr.. The value appears to be declining and may need further review. It has decreased from 83.00 Cr. (Mar 2025) to 80.00 Cr., marking a decrease of 3.00 Cr..
- For Investments, as of Sep 2025, the value is 3.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 3.00 Cr..
- For Other Assets, as of Sep 2025, the value is 1,662.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,425.00 Cr. (Mar 2025) to 1,662.00 Cr., marking an increase of 237.00 Cr..
- For Total Assets, as of Sep 2025, the value is 3,285.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,085.00 Cr. (Mar 2025) to 3,285.00 Cr., marking an increase of 200.00 Cr..
Notably, the Reserves (1,514.00 Cr.) exceed the Borrowings (841.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2020n n 6m | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|
| Free Cash Flow | 105.00 | 15.00 | -120.00 | -482.00 | -856.00 | -685.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|
| Debtor Days | 241 | 92 | 79 | 75 | 101 | 99 |
| Inventory Days | 271 | 152 | 161 | 158 | 185 | 173 |
| Days Payable | 209 | 137 | 144 | 108 | 176 | 159 |
| Cash Conversion Cycle | 302 | 106 | 96 | 124 | 110 | 113 |
| Working Capital Days | 152 | 89 | 57 | 53 | 26 | 20 |
| ROCE % | 19% | 24% | 16% | -3% | 3% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| Motilal Oswal Nifty Microcap 250 Index Fund | 140,745 | 0.19 | 1.06 | 140,745 | 2025-04-22 05:19:08 | 0% |
| Groww Nifty Total Market Index Fund | 369 | 0.01 | 0 | 369 | 2025-04-22 17:25:26 | 0% |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Basic EPS (Rs.) | -0.42 | -4.17 | 9.35 | 11.97 | 7.33 |
| Diluted EPS (Rs.) | -0.42 | -4.17 | 9.35 | 11.97 | 7.33 |
| Cash EPS (Rs.) | 3.83 | -0.54 | 12.38 | 14.43 | 9.33 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 59.58 | 60.07 | 65.64 | 57.65 | 46.13 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 59.58 | 60.07 | 65.64 | 57.65 | 46.13 |
| Revenue From Operations / Share (Rs.) | 81.78 | 61.59 | 100.37 | 98.24 | 64.36 |
| PBDIT / Share (Rs.) | 7.34 | 0.68 | 17.19 | 18.67 | 12.08 |
| PBIT / Share (Rs.) | 3.09 | -2.94 | 14.16 | 16.20 | 10.09 |
| PBT / Share (Rs.) | 0.37 | -4.76 | 12.31 | 16.07 | 9.90 |
| Net Profit / Share (Rs.) | -0.41 | -4.17 | 9.35 | 11.97 | 7.33 |
| NP After MI And SOA / Share (Rs.) | -0.41 | -4.17 | 9.35 | 11.97 | 7.33 |
| PBDIT Margin (%) | 8.97 | 1.11 | 17.12 | 19.00 | 18.76 |
| PBIT Margin (%) | 3.77 | -4.77 | 14.10 | 16.49 | 15.67 |
| PBT Margin (%) | 0.45 | -7.73 | 12.26 | 16.36 | 15.38 |
| Net Profit Margin (%) | -0.50 | -6.76 | 9.31 | 12.18 | 11.39 |
| NP After MI And SOA Margin (%) | -0.50 | -6.76 | 9.31 | 12.18 | 11.39 |
| Return on Networth / Equity (%) | -0.69 | -6.94 | 14.24 | 20.76 | 15.89 |
| Return on Capital Employeed (%) | 4.17 | -3.77 | 16.60 | 23.37 | 18.85 |
| Return On Assets (%) | -0.34 | -3.48 | 7.43 | 10.88 | 9.44 |
| Long Term Debt / Equity (X) | 0.18 | 0.25 | 0.24 | 0.14 | 0.10 |
| Total Debt / Equity (X) | 0.54 | 0.54 | 0.49 | 0.33 | 0.18 |
| Asset Turnover Ratio (%) | 0.67 | 0.50 | 0.85 | 1.06 | 0.89 |
| Current Ratio (X) | 1.12 | 1.15 | 1.42 | 1.39 | 1.62 |
| Quick Ratio (X) | 0.62 | 0.65 | 0.79 | 0.77 | 1.01 |
| Inventory Turnover Ratio (X) | 3.73 | 1.55 | 2.35 | 3.18 | 2.81 |
| Dividend Payout Ratio (NP) (%) | 0.00 | -33.58 | 14.97 | 11.69 | 0.00 |
| Dividend Payout Ratio (CP) (%) | 0.00 | -257.96 | 11.31 | 9.69 | 0.00 |
| Earning Retention Ratio (%) | 0.00 | 133.58 | 85.03 | 88.31 | 0.00 |
| Cash Earning Retention Ratio (%) | 0.00 | 357.96 | 88.69 | 90.31 | 0.00 |
| Interest Coverage Ratio (X) | 2.70 | 0.37 | 6.65 | 50.45 | 27.44 |
| Interest Coverage Ratio (Post Tax) (X) | 0.84 | -1.29 | 4.33 | 32.70 | 17.08 |
| Enterprise Value (Cr.) | 2357.58 | 2831.39 | 2761.81 | 3135.90 | 0.00 |
| EV / Net Operating Revenue (X) | 1.13 | 1.81 | 1.08 | 1.26 | 0.00 |
| EV / EBITDA (X) | 12.63 | 162.66 | 6.32 | 6.61 | 0.00 |
| MarketCap / Net Operating Revenue (X) | 0.74 | 1.29 | 0.77 | 1.06 | 0.00 |
| Retention Ratios (%) | 0.00 | 133.58 | 85.02 | 88.30 | 0.00 |
| Price / BV (X) | 1.03 | 1.32 | 1.18 | 1.81 | 0.00 |
| Price / Net Operating Revenue (X) | 0.74 | 1.29 | 0.77 | 1.06 | 0.00 |
| EarningsYield | -0.01 | -0.05 | 0.12 | 0.11 | 0.00 |
After reviewing the key financial ratios for Meghmani Organics Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
- For Basic EPS (Rs.), as of Mar 25, the value is -0.42. This value is below the healthy minimum of 5. It has increased from -4.17 (Mar 24) to -0.42, marking an increase of 3.75.
- For Diluted EPS (Rs.), as of Mar 25, the value is -0.42. This value is below the healthy minimum of 5. It has increased from -4.17 (Mar 24) to -0.42, marking an increase of 3.75.
- For Cash EPS (Rs.), as of Mar 25, the value is 3.83. This value is within the healthy range. It has increased from -0.54 (Mar 24) to 3.83, marking an increase of 4.37.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 59.58. It has decreased from 60.07 (Mar 24) to 59.58, marking a decrease of 0.49.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 59.58. It has decreased from 60.07 (Mar 24) to 59.58, marking a decrease of 0.49.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 81.78. It has increased from 61.59 (Mar 24) to 81.78, marking an increase of 20.19.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 7.34. This value is within the healthy range. It has increased from 0.68 (Mar 24) to 7.34, marking an increase of 6.66.
- For PBIT / Share (Rs.), as of Mar 25, the value is 3.09. This value is within the healthy range. It has increased from -2.94 (Mar 24) to 3.09, marking an increase of 6.03.
- For PBT / Share (Rs.), as of Mar 25, the value is 0.37. This value is within the healthy range. It has increased from -4.76 (Mar 24) to 0.37, marking an increase of 5.13.
- For Net Profit / Share (Rs.), as of Mar 25, the value is -0.41. This value is below the healthy minimum of 2. It has increased from -4.17 (Mar 24) to -0.41, marking an increase of 3.76.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is -0.41. This value is below the healthy minimum of 2. It has increased from -4.17 (Mar 24) to -0.41, marking an increase of 3.76.
- For PBDIT Margin (%), as of Mar 25, the value is 8.97. This value is below the healthy minimum of 10. It has increased from 1.11 (Mar 24) to 8.97, marking an increase of 7.86.
- For PBIT Margin (%), as of Mar 25, the value is 3.77. This value is below the healthy minimum of 10. It has increased from -4.77 (Mar 24) to 3.77, marking an increase of 8.54.
- For PBT Margin (%), as of Mar 25, the value is 0.45. This value is below the healthy minimum of 10. It has increased from -7.73 (Mar 24) to 0.45, marking an increase of 8.18.
- For Net Profit Margin (%), as of Mar 25, the value is -0.50. This value is below the healthy minimum of 5. It has increased from -6.76 (Mar 24) to -0.50, marking an increase of 6.26.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is -0.50. This value is below the healthy minimum of 8. It has increased from -6.76 (Mar 24) to -0.50, marking an increase of 6.26.
- For Return on Networth / Equity (%), as of Mar 25, the value is -0.69. This value is below the healthy minimum of 15. It has increased from -6.94 (Mar 24) to -0.69, marking an increase of 6.25.
- For Return on Capital Employeed (%), as of Mar 25, the value is 4.17. This value is below the healthy minimum of 10. It has increased from -3.77 (Mar 24) to 4.17, marking an increase of 7.94.
- For Return On Assets (%), as of Mar 25, the value is -0.34. This value is below the healthy minimum of 5. It has increased from -3.48 (Mar 24) to -0.34, marking an increase of 3.14.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.18. This value is below the healthy minimum of 0.2. It has decreased from 0.25 (Mar 24) to 0.18, marking a decrease of 0.07.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.54. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 0.54.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.67. It has increased from 0.50 (Mar 24) to 0.67, marking an increase of 0.17.
- For Current Ratio (X), as of Mar 25, the value is 1.12. This value is below the healthy minimum of 1.5. It has decreased from 1.15 (Mar 24) to 1.12, marking a decrease of 0.03.
- For Quick Ratio (X), as of Mar 25, the value is 0.62. This value is below the healthy minimum of 1. It has decreased from 0.65 (Mar 24) to 0.62, marking a decrease of 0.03.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 3.73. This value is below the healthy minimum of 4. It has increased from 1.55 (Mar 24) to 3.73, marking an increase of 2.18.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has increased from -33.58 (Mar 24) to 0.00, marking an increase of 33.58.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has increased from -257.96 (Mar 24) to 0.00, marking an increase of 257.96.
- For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 133.58 (Mar 24) to 0.00, marking a decrease of 133.58.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 357.96 (Mar 24) to 0.00, marking a decrease of 357.96.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 2.70. This value is below the healthy minimum of 3. It has increased from 0.37 (Mar 24) to 2.70, marking an increase of 2.33.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 0.84. This value is below the healthy minimum of 3. It has increased from -1.29 (Mar 24) to 0.84, marking an increase of 2.13.
- For Enterprise Value (Cr.), as of Mar 25, the value is 2,357.58. It has decreased from 2,831.39 (Mar 24) to 2,357.58, marking a decrease of 473.81.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.13. This value is within the healthy range. It has decreased from 1.81 (Mar 24) to 1.13, marking a decrease of 0.68.
- For EV / EBITDA (X), as of Mar 25, the value is 12.63. This value is within the healthy range. It has decreased from 162.66 (Mar 24) to 12.63, marking a decrease of 150.03.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.74. This value is below the healthy minimum of 1. It has decreased from 1.29 (Mar 24) to 0.74, marking a decrease of 0.55.
- For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 133.58 (Mar 24) to 0.00, marking a decrease of 133.58.
- For Price / BV (X), as of Mar 25, the value is 1.03. This value is within the healthy range. It has decreased from 1.32 (Mar 24) to 1.03, marking a decrease of 0.29.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.74. This value is below the healthy minimum of 1. It has decreased from 1.29 (Mar 24) to 0.74, marking a decrease of 0.55.
- For EarningsYield, as of Mar 25, the value is -0.01. This value is below the healthy minimum of 5. It has increased from -0.05 (Mar 24) to -0.01, marking an increase of 0.04.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Meghmani Organics Ltd:
- Net Profit Margin: -0.5%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 4.17% (Industry Average ROCE: 15.21%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: -0.69% (Industry Average ROE: 19.87%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 0.84
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.62
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 41.5 (Industry average Stock P/E: 31.52)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.54
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: -0.5%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Agro Chemicals/Pesticides | 1st to 3rd Floor, Near Raj Bunglow, Ahmedabad Gujarat 380015 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Ankit Patel | Chairman & Managing Director |
| Mr. Karana Patel | Executive Director |
| Mr. Darshan Patel | Executive Director |
| Mr. Maulik Patel | Non Executive Director |
| Mr. Kaushal Soparkar | Non Executive Director |
| Ms. Urvashi D Shah | Independent Director |
| Mr. Manubhai K Patel | Independent Director |
| Prof. (Dr) Ganapati Yadav | Independent Director |
| Dr. Varesh Govindprasad Sinha | Independent Director |
| Mr. Nikunt Raval | Independent Director |
FAQ
What is the intrinsic value of Meghmani Organics Ltd?
Meghmani Organics Ltd's intrinsic value (as of 04 January 2026) is ₹16.42 which is 74.62% lower the current market price of ₹64.70, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹1,646 Cr. market cap, FY2025-2026 high/low of ₹106/56.1, reserves of ₹1,514 Cr, and liabilities of ₹3,285 Cr.
What is the Market Cap of Meghmani Organics Ltd?
The Market Cap of Meghmani Organics Ltd is 1,646 Cr..
What is the current Stock Price of Meghmani Organics Ltd as on 04 January 2026?
The current stock price of Meghmani Organics Ltd as on 04 January 2026 is ₹64.7.
What is the High / Low of Meghmani Organics Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Meghmani Organics Ltd stocks is ₹106/56.1.
What is the Stock P/E of Meghmani Organics Ltd?
The Stock P/E of Meghmani Organics Ltd is 41.5.
What is the Book Value of Meghmani Organics Ltd?
The Book Value of Meghmani Organics Ltd is 60.6.
What is the Dividend Yield of Meghmani Organics Ltd?
The Dividend Yield of Meghmani Organics Ltd is 0.00 %.
What is the ROCE of Meghmani Organics Ltd?
The ROCE of Meghmani Organics Ltd is 3.39 %.
What is the ROE of Meghmani Organics Ltd?
The ROE of Meghmani Organics Ltd is 0.80 %.
What is the Face Value of Meghmani Organics Ltd?
The Face Value of Meghmani Organics Ltd is 1.00.